Carotid magnetic resonance imaging - A window to study atherosclerosis and identify high-risk plaques

Circulation Journal

Volumn 73, Issue 10, 2009, Pages 1765-1773

  Oikawa, Minako ^a   Ota, Hideki ^c   Takaya, Norihide ^b   Miller, Zach ^d   Hatsukami, Thomas S ^d   Yuan, Chun ^d  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Michigan State University   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Cardiovascular diseases; Carotid arteries; Imaging; Magnetic resonance imaging

Indexed keywords

ROSUVASTATIN; SIMVASTATIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DEFENSE MECHANISM; DIAGNOSTIC IMAGING; DISEASE COURSE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGE RECONSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; THREE DIMENSIONAL IMAGING;

CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RUPTURE; TIME FACTORS;

EID: 70349869229     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0617     Document Type: Review

References (80)

1. Sacco RL, Wolf PA, Gorelick PB. Risk factors and their management for stroke prevention: Outlook for 1999 and beyond. Neurology 1999; 53(Suppl): S15-S24.
2. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: A multifocal disease. Circulation 2003; 107: 2072-2075. (Pubitemid 36532184)
3. Falk E. Why do plaques rupture? Circulation 1992; 86: III-30-III-42.
4. Gillard JH. Imaging of carotid artery disease: From luminology to function? Neuroradiology 2003; 45: 671-680.
5. Virmani R, Ladich ER, Burke AP, Kolodgie FD. Histopathology of carotid atherosclerotic disease. Neurosurgery 2006; 59: S219-S227.
6. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies. Part I. Circulation 2003; 108: 1664-1672. (Pubitemid 37243650)
7. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies. Part II. Circulation 2003; 108: 1772-1778. (Pubitemid 37296082)
8. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-C18.
9. Burke AP, Weber DK, Kolodgie FD, Farb A, Taylor AJ, Virmani R. Pathophysiology of calcium deposition in coronary arteries. Herz 2001; 26: 239-244. (Pubitemid 32612691)
10. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002; 106: 1368-1373. (Pubitemid 35013040)
11. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996; 94: 932-938. (Pubitemid 26292843)
12. Wasserman BA, Wityk RJ, Trout HH III, Virmani R. Low-grade carotid stenosis: Looking beyond the lumen with MRI. Stroke 2005; 36: 2504-2513. (Pubitemid 41566989)
13. Clarke SE, Hammond RR, Mitchell JR, Rutt BK. Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology. Magn Reson Med 2003; 50: 1199-1208.
14. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000; 102: 959-964.
15. Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005; 25: 234-239
16. Serfaty JM, Chaabane L, Tabib A, Chevallier JM, Briguet A, Douek PC. Atherosclerotic plaques: Classification and characterization with T2-weighted high-spatial-resolution MR imaging: An in vitro study. Radiology 2001; 219: 403-410. (Pubitemid 32336353)
17. Li ZY, Tang T, U-King-Im J, Graves M, Sutcliffe M, Gillard JH. Assessment of carotid plaque vulnerability using structural and geometrical determinants. Circ J 2008; 72: 1092-1099. (Pubitemid 351957074)
18. Yuan C, Kerwin WS, Yarnykh VL, Cai J, Saam T, Chu B, et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006; 19: 636-654.
19. Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001; 104: 2051-2056.
20. Chu B, Zhao XQ, Saam T, Yarnykh VL, Kerwin WS, Flemming KD, et al. Feasibility of in vivo, multicontrast-weighted MR imaging of carotid atherosclerosis for multicenter studies. J Magn Reson Imaging 2005; 21: 809-817. (Pubitemid 40770874)
21. Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B, et al. In vivo quantative measurement of intact fibrous cap and lipid rich necrotic core size in atherosclerotic carotid plaque: A comparison of high resolution contrast enhanced MRI and histology. Circulation 2005; 112: 3437-3444.
22. Takaya N, Cai J, Ferguson MS, Yarnykh VL, Chu B, Saam T, et al. Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging 2006; 24: 203-210.
23. Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, et al. Contrast enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002; 15: 62-67. (Pubitemid 34008147)
24. Moody AR, Murphy RE, Morgan PS, Martel AL, Delay GS, Allder S, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003; 107: 3047-3052. (Pubitemid 36758978)
25. Underhill H, Kerwin WS, Hatsukami TS, Yuan C. Automated measurement of mean wall thickness in the common carotid artery by MRI: A comparison to intima-media thickness by B-mode ultrasound. J Magn Reson Imag 2005; 21: 809-817. (Pubitemid 44188565)
26. Mani V, Aguiar SH, Itskovich VV, Weinshelbaum KB, Postley JE, Wasenda EJ, et al. Carotid black blood MRI burden of atherosclerotic disease assessment correlates with ultrasound intima-media thickness. J Cardiovasc Magn Reson 2006; 8: 529-534.
27. Luo Y, Polissar N, Han C, Yarnykh V, Kerwin WS, Hatsukami TS, et al. Accuracy and uniqueness of three in vivo measurements of atherosclerotic carotid plaque morphology with black blood MRI. Magn Reson Med 2003; 50: 75-82. (Pubitemid 36841862)
28. Yuan C, Beach KW, Smith LH Jr, Hatsukami TS. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 1998; 98: 2666-2671. (Pubitemid 28564000)
29. Shinnar M, Fallon JT, Wehrli S, Levin M, Dalmacy D, Fayad ZA, et al. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol 1999; 19: 2756-2761.
30. Cappendijk VC, Cleutjens KB, Heeneman S, Schurink GW, Welten RJ, Kessels AG, et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging 2004; 20: 105-110.
31. Chu B, Kampschulte A, Ferguson MS, Kerwin WS, Yarnykh VL, O'Brien KD, et al. Hemorrhage in the atherosclerotic carotid plaque: A high-resolution MRI study. Stroke 2004; 35: 1079-1084. (Pubitemid 38543521)
32. Mitsumori LM, Hatsukami TS, Ferguson MS, Kerwin WS, Cai J, Yuan C. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J Magn Reson Imaging 2003; 17: 410-420.
33. Trivedi RA, U-King-Im J, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, et al. Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 2004; 28: 207-213. (Pubitemid 38967276)
34. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
35. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
36. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
37. de Boer OJ, van der Wal AC, Teeling P, Becker AE. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: A prominent role for neovascularization? Cardiovasc Res 1999; 41: 443-449.
38. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-4741. (Pubitemid 36457799)
39. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945-951. (Pubitemid 23262418)
40. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93: 672-682. (Pubitemid 26052452)
41. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 2008; 59: 507-514. (Pubitemid 351348221)
42. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in carotid atherosclerotic plaque: A dynamic contrast-enhanced MR imaging study. Radiology 2006; 241: 459-468. (Pubitemid 44632892)
43. Tang T, Howarth SPS, Miller SR, Trivedi R, Graves MJ, King-Im JU, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006; 37: 2266-2270. (Pubitemid 44337167)
44. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, U-King- Im J, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study: Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009; 53: 2039-2050.
45. Yarnykh VL, Terashima M, Hayes CE, Shimakawa A, Takaya N, Nguyen PK, et al. Multicontrast black-blood MRI of carotid arteries: Comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Reson Imaging 2006; 23: 691-698.
46. Underhill HR, Yarnykh VL, Hatsukami TS, Wang J, Balu N, Hayes CE, et al. Carotid plaque morphology and composition: Initial comparison between 1.5- and 3.0-T magnetic field strengths. Radiology 2008; 248: 550-560.
47. Underhill HR, Yuan C, Terry JG, Chen H, Espeland MA, Hatsukami TS, et al. Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: A cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2008; 10: 31.
48. Kerwin WS, Liu F, Yarnykh V, Underhill H, Oikawa M, Yu W, et al. Signal features of the atherosclerotic plaque at 3.0 Tesla versus 1.5 Tesla: Impact on automatic classification. J Magn Reson Imaging 2008; 28: 987-995.
49. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, et al. Identification of fibrous cap rapture with magnetic resonance imaging is highly associated with recent TIA or stroke. Circulation 2002; 105: 181-185.
50. Saam T, Cai J, Ma L, Cai YQ, Ferguson MS, Polissar NL, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006; 240: 464-472. (Pubitemid 44098643)
51. Tang TY, Howarth SP, Walsh SR, Gaunt ME, Gillard JH. Contralateral carotid intraplaque hemorrhage may reduce the predictive value of fat-suppressed T1-weighted MRI in symptomatic carotid disease. Stroke 2007; 38: e156-e157.
52. Tang TY, Howarth SP, Miller SR, Graves MJ, U-King-Im JM, Trivedi RA, et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: An ultra small superparamagnetic iron oxide enhanced magnetic resonance study. J Neurol Neurosurg Psychiatry 2007; 78: 1337-1343.
53. Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: A prospective assessment with MRI-initial results. Stroke 2006; 37: 818-823. (Pubitemid 43731915)
54. Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 2007; 194: e34-e42. (Pubitemid 47513067)
55. Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, et al. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 2009; 73: 718-725.
56. Yamada T, Azuma A, Sasaki S, Sawada T, Matsubara H. Randomized evaluation of atorvastatin in patients with coronary heart disease: A serial intravascular ultrasound study. Circ J 2001; 71: 1845-1850.
57. Takashima H, Ozaki Y, Yasukawa T, Waseda K, Asai K, Wakita Y, et al. Impact of lipid-lowering therapy with pravastatin, a new HMG- CoA reductase inhibitor, on regression of coronary atherosclerotic plaque. Circ J 2007; 71: 1678-1684.
58. Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, et al; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: The METEOR Trial. JAMA 2007; 297: 1344-1353.
59. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001; 104: 249-252.
60. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, et a. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002; 106: 2884-2887.
61. Zhao XQ, Yuan C, Hatsukami TS, Frechette EH, Kang XJ, Maravilla KR, et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study. Arterioscler Thromb Vasc Biol 2001; 21: 1623-1629. (Pubitemid 34215582)
62. Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high- resolution magnetic resonance imaging trial. Am Heart J 2008; 155: 584.e1-e8.
63. Richardson PD. Biomechanics of plaque rupture: Progress, problems, and new frontiers. Ann Biomed Eng 2002; 30: 524-536.
64. Li ZY, Gillard JH. Simulation of the Interaction between blood flow and atherosclerotic plaque. Proc IEEE Eng Med Biol Soc 2007; 1: 1699-1702.
65. Li ZY, Howarth S, Trivedi RA, U-King-Im JM, Graves MJ, Brown A, et al. Stress analysis of carotid plaque rapture based on in vivo high resolution MRI. J Biomech 2006; 39: 2611-2622. (Pubitemid 44468398)
66. Tang D, Yang C, Zheng J, Woodard PK, Sicard GA, Saffitz JE, et al. 3D MRI-based multicomponent FSI models for atherosclerotic plaques. Ann Biomed Eng 2004; 32: 947-960. (Pubitemid 40026931)
67. Tang TY, Howarth SP, Li ZY, Miller SR, Graves MJ, U-King-Im JM, et al. Correlation of carotid atheromatous plaque inflammation with biomechanical stress: Utility of USPIO enhanced MR imaging and finite element analysis. Stroke 2008; 39: 2144-2147.
68. Groen HC, Gijsen FJ, van der Lugt A, Ferguson MS, Hatsukami TS, van der Steen AF, et al. Plaque rupture in the carotid artery is localized at the high shear stress region: A case report. Stroke 2007; 38: 2379-2381.
69. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: The Edinburgh Artery Study. Stroke 1997; 28: 348-353.
70. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997; 96: 1432-1437. (Pubitemid 27375333)
71. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case-control study. Circulation 1990; 82: 1230-1242.
72. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
73. Underhill HR, Yuan C, Espeland MA, Chen H, Terry JG, Hatsukami TS, et al. The composition and morphology of the carotid artery are associated with coronary artery disease: A case-control high resolution magnetic resonance imaging study [Abstract, Scientific Sessions of the American Heart Association 2006]. Circulation 2006; 114(Suppl):II-823 (3843).
74. Ruan L, Chen W, Srinivasan SR, Sun M, Wang H, Toprak A, et al. Correlates of common carotid artery lumen diameter in black and white younger adults: The Bogalusa Heart Study. Stroke 2009; 40: 702-707.
75. Manolio TA, Arnold AM, Post W, Bertoni AG, Schreiner PJ, Sacco RL, et al. Ethnic differences in the relationship of carotid atherosclerosis to coronary calcification: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008; 197: 132-138. (Pubitemid 351273232)
76. D'Agostino RB, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, et al. Ethnic differences in carotid wall thickness: The Insulin Resistance Atherosclerosis Study. Stroke 1996; 27: 1744-1749. (Pubitemid 26332497)
77. Saam T, Cai JM, Cai YQ, An NY, Kampschulte A, Xu D, et al. Carotid plaque composition differs between ethno-racial groups: An MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol 2005; 25: 611-616.
78. Miyauchi K, Takaya N, Hirose T, Ikeda F, Kawamori R, Ohishi H, et al. Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): Evaluation by magnetic resonance imaging. Circ J 2009; 73: 111-115.
79. Balu N, Chu B, Hatsukami TS, Yuan C, Yarnykh VL. Comparison between 2D and 3D high-resolution black-blood techniques for carotid artery wall imaging in clinically significant atherosclerosis. J Magn Reson Imaging 2008; 27: 918-924.
80. Osborn EA, Jaffer FA. Advances in molecular imaging of atherosclerotic vascular disease. Curr Opin Cardiol 2008; 23: 620-628.